Alerts will be sent to your verified email
Verify EmailTHYROCARE
Thyrocare Tech.
|
Metropolis Health.
|
Vimta Labs
|
|
---|---|---|---|
Operational Metrics
|
|||
Hospital Sector
|
|||
Number of Daily Patients - Diagnostic Centres
|
45.75 Ths | 35.11 Ths | n/a |
Number of Samples - Quarterly
|
5.9 Million | n/a | n/a |
No of Tests - Quarterly
|
41.98 Mn | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
20.41 % | 17.42 % | 12.51 % |
5yr average Equity Multiplier
|
1.35 | 1.7 | 1.33 |
5yr Average Asset Turnover Ratio
|
0.84 | 0.72 | 0.82 |
5yr Avg Net Profit Margin
|
18.13 % | 13.94 % | 11.37 % |
Price to Book
|
12.83 | 7.93 | 8.09 |
P/E
|
65.9 | 72.76 | 43.39 |
5yr Avg Cash Conversion Cycle
|
-55.2 Days | -103.57 Days | 122.88 Days |
Inventory Days
|
19.62 Days | 13.03 Days | 26.64 Days |
Days Receivable
|
30.92 Days | 37.6 Days | 95.75 Days |
Days Payable
|
64.69 Days | 144.74 Days | 309.83 Days |
5yr Average Interest Coverage Ratio
|
65.11 | 11.6 | 21.55 |
5yr Avg ROCE
|
26.01 % | 18.91 % | 16.46 % |
5yr Avg Operating Profit Margin
|
30.0 % | 25.91 % | 25.53 % |
5 yr average Debt to Equity
|
0.01 | 0.08 | 0.11 |
5yr CAGR Net Profit
|
-4.08 % | -4.56 % | 43.08 % |
5yr Average Return on Assets
|
14.94 % | 10.32 % | 9.62 % |
Shareholdings
|
|||
Promoter Holding
|
71.06 % | 48.89 % | 36.67 % |
Share Pledged by Promoters
|
100.0 % | 1.18 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.12 % | -0.9 % | -0.79 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.94 % | 17.05 % | -1.48 % |
Thyrocare Tech.
|
Metropolis Health.
|
Vimta Labs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
-
|
Capex
|
Capex
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Pathology vs Radiology
|
Pathology vs Radiology
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|